Enteral Feeding Devices Market Size, Share, and Trends 2024 to 2034

The global enteral feeding devices market size is calculated at USD 4.96 billion in 2025 and is forecasted to reach around USD 7.67 billion by 2034, accelerating at a CAGR of 4.95% from 2025 to 2034. The North America enteral feeding devices market size surpassed USD 1.80 billion in 2024 and is expanding at a CAGR of 4.98% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1226
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Enteral Feeding Devices Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Enteral Feeding Devices Market

5.1. Covid-19: Enteral Feeding Devices Industry Impact
5.2. Enteral Feeding Devices Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Enteral Feeding Devices Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Enteral Feeding Devices Market Players to deal with Covid-19 Pandemic Scenario

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Integration of safety and programming features within the feeding devices
6.1.1.2. Development of portable feeding devices
6.1.2. Market Restraints
6.1.2.1. Complications associated with enteral feeding devices
6.1.3. Market Opportunities
6.1.3.1. Rapidly increasing awareness regarding enteral feeding
6.1.3.2. Increased focus on the improvement of healthcare infrastructure

Chapter 7. Global Enteral Feeding Devices Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Enteral Feeding Devices Market Revenue by Market Players
7.1.1.2. Enteral Feeding Devices Market Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Enteral Feeding Devices Market, By Product Type

8.1. Enteral Feeding Devices Market, by Product Type, 2024-2034
8.1.1. Administration Sets
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Enteral Feeding Pump
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Enteral Syringe
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Enteral Feeding Tube
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Others
8.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Enteral Feeding Devices Market, By Application

9.1. Enteral Feeding Devices Market, by Application, 2024-2034
9.1.1. Gastrointestinal Disease
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Malnutrition
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Neurological Disorder
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Enteral Feeding Devices Market, By Age Group

10.1. Enteral Feeding Devices Market, by Age Group, 2021-2034
10.1.1. Pediatrics
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Adult
10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Enteral Feeding Devices Market, By End-User

11.1. Enteral Feeding Devices Market, by End User, 2024-2034
11.1.1. Gastrointestinal Disease
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cancer
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Malnutrition
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Neurological Disorder
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Enteral Feeding Devices Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product Type(2021-2034)
12.1.2. Market Revenue Forecast by Application (2021-2034)
12.1.3. Market Revenue Forecast by Age Group (2021-2034)
12.1.4. Market Revenue Forecast by End User (2021-2034)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2021-2034)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2021-2034)
12.2. Europe
12.2.1. Market Revenue Forecast by Product Type (2021-2034)
12.2.2. Market Revenue Forecast by Application (2021-2034)
12.2.3. Market Revenue Forecast by Age Group (2021-2034)
12.2.4. Market Revenue Forecast by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2021-2034)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2021-2034)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product Type (2021-2034)
12.3.2. Market Revenue Forecast by Application (2021-2034)
12.3.3. Market Revenue Forecast by Age Group (2021-2034)
12.3.4. Market Revenue Forecast by End User (2021-2034)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2021-2034)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2021-2034)
12.4. LATAM
12.4.1. Market Revenue Forecast by Product Type (2021-2034)
12.4.2. Market Revenue Forecast by Application (2021-2034)
12.4.3. Market Revenue Forecast by Age Group (2021-2034)
12.4.4. Market Revenue Forecast by End User (2021-2034)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2021-2034)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2021-2034)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product Type (2021-2034)
12.5.2. Market Revenue Forecast by Application (2021-2034)
12.5.3. Market Revenue Forecast by Age Group (2021-2034)
12.5.4. Market Revenue Forecast by End User (2021-2034)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2021-2034)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2021-2034)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2021-2034)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2021-2034)

Chapter 13. Company Profiles

13.1. Cook Medical
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Abott Laboratories
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Fresenius Kabi
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Halyard Health
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. Medtronic
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. Moog, Inc
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Nestle Health Science
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. VYGON
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Danone
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Cardinal Health
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies
13.11. B.Braun
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin
13.11.4. Recent Developments and Strategies
13.12. Boston Scientific
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin
13.12.4. Recent Developments and Strategies
13.13. C.R. Bard
13.13.1. Company Overview, Business Information, Regional Presence
13.13.2. Product Portfolio Analysis
13.13.2.1. Product Details, Specification, Application
13.13.3. Revenue, Price, and Gross Margin
13.13.4. Recent Developments and Strategies
13.14. Conmed Corporation
13.14.1. Company Overview, Business Information, Regional Presence
13.14.2. Product Portfolio Analysis
13.14.2.1. Product Details, Specification, Application
13.14.3. Revenue, Price, and Gross Margin
13.14.4. Recent Developments and Strategies

Chapter 14. Appendix

 14.1. About Us
14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global enteral feeding devices market size was valued at USD 4.73 billion in 2024 is anticipated to reach USD 7.67 billion by 2034.

An enteral feeding device can be described as a medical device that is used to transport nutrition to individuals who cannot gain nutrition through mouth and are incapable of swallowing securely, or require enteral feeding devices.

The global enteral feeding devices market is exhibiting CAGR of 4.95% during the estimate period 2025 to 2034.

Integration of safety and programming features within the feeding devices, development of portable feeding devices, growing number of preterm child birth, increasing healthcare expenditure, and increasing geriatric population are among major factors boosting growth of the global industry. Additionally, increasing prevalence of chronic ailments such as cancer and diabetes is fueling growth of the enteral feeding devices market worldwide. Moreover, rapidly increasing awareness regarding enteral feeding is having positive impact on the growth of global industry. Further, increased focus on the improvement of healthcare infrastructure in developing regions and growing investment by major market players on research and development are other factors to boost growth of the global market during th

The enteral feeding pump segment displayed a major share in the worldwide enteral feeding devices market in 2024. Technological advancements in the feeding pumps are expected to boost the growth of the segment in the near future.

By region, enteral feeding devices market is led by North America due to higher healthcare spending, presence of modern healthcare set-up, and availability of latest products.

The major companies functioning in the worldwide enteral feeding devices are Cook Medical, Abott Laboratories, Fresenius Kabi, Halyard Health, Medtronic, Moog, Inc, Nestle Health Science, VYGON, Danone, Cardinal Health, B.Braun, Boston Scientific, C.R. Bard, and Conmed Corporation among others.

Asia Pacific is anticipated to grow at the fastest CAGR majorly due to increasing incidence of cancer and gastrointestinal ailments, high rate of preterm child birth, and increasing number of hospital admissions.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client